About the ForteoŽ Patient Registry

What was the purpose of the Forteo Patient Registry?

The Forteo Patient Registry enrolled patients from Sept 2009 - June 2019. The study is no longer enrolling patients. The Forteo Patient Registry was implemented to help us learn more about the long-term safety of using this medication, specifically the potential risk of osteosarcoma, a rare bone cancer. Forteo is used in men and postmenopausal women with osteoporosis who are at high risk for having broken bones. Forteo is also used in men and women with osteoporosis due to use of glucocorticoids, such as prednisone, for several months who are at high risk for having broken bones. The safety of Forteo has been studied for over 15 years.

Additional Information About the Registry

Frequently Asked Questions

If you have questions about Forteo, please contact Eli Lilly and Company directly or talk to your doctor.

You may contact Eli Lilly and Company by calling 1-800-LillyRx (1-800-545-5979) or visiting www.Forteo.com.